ArcStone Securities and Investments Corp. Publishes Industry Report on The Rapid Expansion of The Oral Stimulant Pouch Market

Industry Overview - The oral stimulant pouch market is identified as a rapidly emerging, multi-billion dollar sector within the health and wellness consumer industry [1] - The market is characterized by high growth potential, driven by increasing consumer demand for innovative health products [1] Company Focus: Mangoceuticals, Inc. - Mangoceuticals, Inc. is highlighted as a key player in the oral stimulant pouch market, strategically positioned to leverage its proprietary science and intellectual property [2] - The company has acquired exclusive North American rights to Diabetinol, a clinically validated supplement for prediabetes and Type II diabetes, which supports future product development in oral pouches [2][9] - Mangoceuticals has appointed Tim Corkum, a veteran with 20 years of experience at Philip Morris International, as President of the Pouch Division to lead its expansion efforts [3] Market Position and Strategy - Mangoceuticals is noted as one of the few publicly listed companies entering the oral stimulant category at scale, with a strong IP portfolio and a tight float [4] - The company is well-positioned to execute an aggressive, asset-light roll-up strategy in the rapidly expanding sector, capitalizing on significant market opportunities [4]